Sign up to save your podcasts
Or
Share NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. DOI: 10.1056/NEJMe2414471.
View all episodes
By NEJM Group
4.4
120120 ratings
Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. DOI: 10.1056/NEJMe2414471.
More shows like NEJM Interviews
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
316 Listeners
JAMA Clinical Reviews
497 Listeners
JACC This Week
169 Listeners
Clinical Conversations
58 Listeners
Mayo Clinic Talks
297 Listeners
BMJ Best Practice Podcast
22 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
136 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Curbside Consults
91 Listeners
Leadership Conversations
5 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners
The Curious Clinicians
370 Listeners
NEJM AI Grand Rounds
60 Listeners
Intention to Treat
31 Listeners
Not Otherwise Specified
66 Listeners